Besides, different extracellular mediators acting via G protein-coupled receptors (GPCRs) such as incretins, adrenergic, and muscarinic agonists, as well as signals from nutrient receptors, converge on the -cell to finely modulate insulin release [2,3,4,5]
This long half-life provides a buffer that prevents the medications effects from disappearing the moment a dose is missed
Cost-benefit analysis helps assess whether continued annual therapy provides sufficient value relative to investment
These medications are recommended for individuals with a BMI of at least 30 kg/m or 27 kg/m if accompanied by obesity-related health issues like type 2 diabetes, hypertension, or dyslipidemia
Identify your insurance type: Are you covered by an employer plan, Marketplace, Medicare Part D, or Medicaid
As we age, hormonal changes, menopause, and a slowing metabolism can make losing weight more difficult than ever